Sandeep K. Reddy, MD
Senior Vice President, Chief Medical Officer
Caris Life Sciences
6655 N MacArthur Blvd
Irving,
TX
USA
75039
Papers:
43
Identification of potential therapeutic targets by molecular profiling of 628 cases of uterine serous carcinoma
141
Molecular characterization of 361 cases of uterine carcinosarcomas reveal alterations in the DNA repair and PI3K pathways as potential therapeutic targets
240
Identifying potential therapeutics by molecular profiling of 136 cases of uterine clear cell carcinoma
347
Microarray analysis of vascular endothelial growth factor (VEGF)-dependent angiogenic biomarkers in squamous cell carcinoma (SCCA) and adenocarcinoma (AC) of the cervix
348
Paving the road to personalized medicine in cervical cancer: theranostic biomarker evaluation in a 592-specimen library
381
Molecular profile of uterine papillary serous carcinoma compared to ovarian serous carcinoma: is it the same disease at different site?
383
Distinct molecular landscapes between endometrioid and non-endometrioid uterine carcinoma
421
Identifying therapeutic options in small cell cervical cancer by multiplatform evaluation of biomarker alterations
509
PD-1, PD-L1 expression in 1599 gynecological cancers: implications for immunotherapy
519
Biomarker comparison of epithelial ovarian cancer and endometrial cancer by multiplatform tumor profiling